Atenolol developmental toxicity: Animal-to-human comparisons

Birth Defects Research Part A - Clinical and Molecular Teratology

Volumn 67, Issue 3, 2003, Pages 181-192

  Tabacova, Sonia ^a,d   Kimmel, Carole A ^b   Wall, Kelly ^c   Hansen, Deborah ^c  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ARTICLE; BRADYCARDIA; CLINICAL TRIAL; DEVELOPMENTAL DISORDER; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; EMBRYOTOXICITY; FETOTOXICITY; FETUS MALFORMATION; FETUS WEIGHT; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL HYPERTENSION; NEWBORN DISEASE; NONHUMAN; PLACENTA DISORDER; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; SPONTANEOUS ABORTION; STILLBIRTH;

ABNORMALITIES, DRUG-INDUCED; ADULT; ANIMALS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; FEMALE; HUMANS; MODELS, ANIMAL; RABBITS; RATS; SPECIES SPECIFICITY; TERATOGENS;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 0141925972     PISSN: 15420752     EISSN: None     Source Type: Journal    
DOI: 10.1002/bdra.10011     Document Type: Article

References (32)

1. Butters L, Kennedy S, Rubin PC. 1990. Atenolol in essential hypertension during pregnancy. BMJ 301:587-589.
2. Crichton F. 1996. Beta-blockers in pregnancy and their effect on regional Doppler ultrasound and fetal weight. J Clin Obstet Gynecol 23:15-17.
3. Chapin RE, Sloane RA. 1997. Reproductive assessment by continuous breeding: evolving study design and summaries of eighty-eight studies. Environ Health Perspect 105(Suppl):199-205.
4. Dubois D, Petitcolas J, Temperville B, Klepper A, Catherine PH. 1982. Treatment of hypertension in pregnancy with beta-adrenoreceptor antagonists. Br J Clin Pharmacol 13(Suppl):375-378.
5. Dubois D, Petitcolas J, Temperville B, Klepper A, Catherine PH. 1983. Beta blocker therapy in 125 cases of hypertension during pregnancy. Clin Exp Hypertens B:41-59.
6. Easterling TR, Brateng D, Schmucker B, Brown Z, Millard SP. 1999. Prevention of preeclampsia: a randomized trial of atenolol in hyperdynamic patients before onset of hypertension. Obstet Gynecol 93:725-733.
7. Esaki K, Imai K. 1980. Effects of oral administration of atenolol on reproduction in rats. Jitchuken Zenrinsho Kenkyu Ho. CIEA Preclinical Reports 6:239-246.
8. Fabregues G, Alvarez L, Varas Juri P, Drisaldi S, Cerrato C, Moschettoni C, Pituelo D, Baglivo HP, Esper RJ. 1992. Effectiveness of atenolol in the treatment of hypertension during pregnancy. Hypertension 19(Suppl): 129-131.
9. Fitzgerald JD. 1979. Atenolol. In: Goldberg ME, editor. Pharmacological and biochemical properties of drug substances. Washington, DC: American Pharmaceutical Association. pp. 2:98-147.
10. Hack M, Flannery DJ, Schluchter M, Cartar L, Borawski E, Klein N. 2002. Outcomes in young adulthood for very-low-birth-weight infants. N Engl J Med 346:149-157.
11. Hill AB. 1965. The environment and disease: association or causation? Proc R Soc Med 58:295-300.
12. Katz V, Blanchard BA, Dingman K, Bowes WA Jr, Cefalo RC. 1987. Atenolol and short umbilical cords. Am J Obstet Gynecol 156:1271-1272.
13. Kramer MS, Platt R, Yang H, McNamara H, Usher RH. 1999. Are all growth-restricted infants created equal(ly)? Pediatrics 1999:103:599-602.
14. Lardoux H, Gerard J, Blazquez G, Chouty F, Flouvat B. 1983. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol. Eur Heart J 4(Suppl):35-40.
15. Liedholm H. 1983. Atenolol in the treatment of hypertension of pregnancy. Drugs 25:206-211.
16. Lip GYH, Beevers M, Churchill D, Shaffer LM, Beevers DG. 1997. Effect of atenolol on birth weight. Am J Cardiol 79:436-438.
17. Loquet P, Renier M, Buytaert P. 1988. The influence of atenolol and pindolol on umbilical artery pulsatility index in non-proteinuric hypertension in pregnancy. XII World Congress of Gynecology and Obstetrics, October 23-28, Rio de Janeiro, Brazil.
18. Marlettini MG, Crippa S, Morselli-Labate AM, Contarini A, Orlandi C. 1990. Randomized comparison of calcium antagonists and beta-blockers in the treatment of pregnancy-induced hypertension. Curr Ther Res 48:684-694.
19. Montan S, Ingemarsson I, Marsal K, Sjoberg N-O. 1992. Randomized controlled trial of atenolol and pindolol in human pregnancy: effects on fetal haemodynamics. BMJ 304:946-949.
20. Physicians' Desk Reference. 2001. 55th Ed. Montvale, NJ: Medical Econ Company.
21. Redman C. 1982. Screening for pre-eclampsia. In: Enkin M, Chalmers I, editors. Effectiveness and satisfaction in antenatal care. London: W. Heinemann Medical Books. p. 69.
22. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. 2000. Am J Obstet Gynecol 183(Suppl):1-22.
23. Reynolds D, Butters L, Evans J, Adams T, Rubin PC. 1984. First year of life after the use of atenolol in pregnancy-associated hypertension. Arch Dis Child 59:1061-1063.
24. Rubin PC, Butters L, Clark DM, Reynolds B, Sumner DJ, Steedman D, Low RA, Reid JL. 1983. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension. Lancet 1:431-434.
25. Rubin PC, Butters L, Clark DM, Sumner DJ, Belfield A, Pledger D, Low RA, Reid JL. 1984. Obstetric aspects of the use in pregnancy-associated hypertension of the beta-adrenoreceptor antagonist atenolol. Am J Obstet Gynecol 150:389-392.
26. Ryan CL, Pappas BA. 1990. Prenatal exposure to antiadrenergic antihypertensive drugs: effect on neurobehavioral development and the behavioral consequences of enriched rearing. Neurotoxicol Teratol 12:359-366.
27. Sarda P, Dupuy RP, Boulot P, Rieu D. 1992. Brainstem conduction time abnormalities in small for gestational age infants. J Perinat Med 20:57-63.
28. Sibai B, Lindheimer M, Hauth J, Caritis S, VanDorsten P, Klebanoff M, MacPherson C, Landon M, Miodovnik M, Paul R, Meis P, Dombrowski M. 1998. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. N Engl J Med 339:667-671.
29. Speiser Z, Gordon I, Rehavi M, Gitter S. 1991. Behavioral and biochemical studies in rats following prenatal treatment with beta-adrenoceptor antagonists. Eur J Pharmacol 195:75-83.
30. Svenningsen NW, Liedholm H, Aberg A. 1984. Hypertension in pregnancy and the infant. Acta Obstet Gynecol Scand 1(Suppl):103-106.
31. Tabacova S, Kimmel CA. 2002. Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity. A review. Reprod Toxicol 16: 1-7.
32. Tiumala R, Hartikainen-Sorri A-L. 1988. Randomized comparison of atenolol and pindolol for treatment of hypertension in pregnancy. Curr Ther Res 44:579-584.